Cite
Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling.
MLA
Dalziel, Kim, et al. “Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling.” PharmacoEconomics, vol. 38, no. 5, May 2020, pp. 499–513. EBSCOhost, https://doi.org/10.1007/s40273-020-00884-9.
APA
Dalziel, K., Catchpool, M., García-Lorenzo, B., Gorostiza, I., Norman, R., & Rivero-Arias, O. (2020). Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling. PharmacoEconomics, 38(5), 499–513. https://doi.org/10.1007/s40273-020-00884-9
Chicago
Dalziel, Kim, Max Catchpool, Borja García-Lorenzo, Inigo Gorostiza, Richard Norman, and Oliver Rivero-Arias. 2020. “Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling.” PharmacoEconomics 38 (5): 499–513. doi:10.1007/s40273-020-00884-9.